Literature DB >> 19244108

Mdm2 affects genome stability independent of p53.

Alyssa Bouska1, Christine M Eischen.   

Abstract

Mdm2 is a critical negative regulator of the p53 tumor suppressor and is frequently overexpressed in human cancers. However, reports, including our own studies, suggest that Mdm2 has both p53-dependent and p53-independent functions that contribute to genomic instability and transformation when deregulated. We recently elucidated a p53-independent role for Mdm2 in the regulation of the DNA double-strand break repair response, genomic stability, and transformation through interaction with Nbs1, a member of the Mre11/Rad50/Nbs1 DNA double-strand break repair complex. In light of these findings, targeting Mdm2 in human malignancies may have effects other than activating p53.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244108     DOI: 10.1158/0008-5472.CAN-08-3732

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

Review 1.  MDM2 SNP309 is associated with endometrial cancer susceptibility: a meta-analysis.

Authors:  Yan Li; Hongjin Zhao; Li Sun; Linjuan Huang; Qifeng Yang; Beihua Kong
Journal:  Hum Cell       Date:  2011-03-04       Impact factor: 4.174

2.  Human Oncoprotein MDM2 Up-regulates Expression of NF-κB2 Precursor p100 Conferring a Survival Advantage to Lung Cells.

Authors:  Catherine Vaughan; Lathika Mohanraj; Shilpa Singh; Catherine I Dumur; Mahesh Ramamoorthy; Carleton T Garrett; Brad Windle; W Andrew Yeudall; Sumitra Deb; Swati Palit Deb
Journal:  Genes Cancer       Date:  2011-10

3.  Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck.

Authors:  Hongping Yu; Yu-jing Huang; Zhensheng Liu; Li-E Wang; Guojun Li; Erich M Sturgis; David G Johnson; Qingyi Wei
Journal:  Mol Carcinog       Date:  2011-06-07       Impact factor: 4.784

4.  Tissue-specific and age-dependent effects of global Mdm2 loss.

Authors:  Yun Zhang; Shunbin Xiong; Qin Li; Sophia Hu; Mehrnoosh Tashakori; Carolyn Van Pelt; Mingjian James You; Laura Pageon; Guillermina Lozano
Journal:  J Pathol       Date:  2014-06-09       Impact factor: 7.996

Review 5.  Reviving the guardian of the genome: Small molecule activators of p53.

Authors:  Daniel Nguyen; Wenjuan Liao; Shelya X Zeng; Hua Lu
Journal:  Pharmacol Ther       Date:  2017-03-27       Impact factor: 12.310

6.  Daxx is reciprocally regulated by Mdm2 and Hausp.

Authors:  Jun Tang; Like Qu; Mingsu Pang; Xiaolu Yang
Journal:  Biochem Biophys Res Commun       Date:  2010-02-12       Impact factor: 3.575

7.  Using Mouse Models to Explore MDM-p53 Signaling in Development, Cell Growth, and Tumorigenesis.

Authors:  Hugh S Gannon; Stephen N Jones
Journal:  Genes Cancer       Date:  2012-03

8.  Splicing up mdm2 for cancer proteome diversity.

Authors:  Danielle R Okoro; Melissa Rosso; Jill Bargonetti
Journal:  Genes Cancer       Date:  2012-03

9.  Mdm2 and tumorigenesis: evolving theories and unsolved mysteries.

Authors:  Emir Senturk; James J Manfredi
Journal:  Genes Cancer       Date:  2012-03

Review 10.  p53-independent roles of MDM2 in NF-κB signaling: implications for cancer therapy, wound healing, and autoimmune diseases.

Authors:  Dana Thomasova; Shrikant R Mulay; Hauke Bruns; Hans-Joachim Anders
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.